Insomnia News and Research

Latest Insomnia News and Research

Common medications reduce brain plaques in mice

Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical Center. The findings are published online in the journal PLoS One.

13 Jun 2013

Binge drinking more than 2 days per week is associated with insomnia symptoms

A new study suggests that frequent binge drinking is associated with insomnia symptoms in older adults.

11 Jun 2013

Review on new, hazardous drugs of abuse presented in Journal of Addiction Medicine

The last few years have seen the emergence of a new drug problem in so-called "bath salts"-actually "designer stimulants," packaged and sold in ways that skirt drug laws. A review and update on these designer drugs is presented in the June Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

5 Jun 2013

People with narcolepsy have increased number of neurons that produce histamine

A new study provides surprising evidence that people with narcolepsy have an increased number of neurons that produce histamine, suggesting that histamine signaling may be a novel therapeutic target for this potentially disabling sleep disorder.

4 Jun 2013

Study demonstrates link between workplace daylight exposure to sleep, quality of life

A new study demonstrates a strong relationship between workplace daylight exposure and office workers' sleep, activity and quality of life.

4 Jun 2013

Sleep deprivation increases men's perceptions of women's interest in sex

A new study suggests that one night of sleep deprivation leads to an increase in men's perceptions of both women's interest in and intent to have sex.

1 Jun 2013

Study suggests bright light therapy may improve sleep and brain function post mild TBI

A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI).

1 Jun 2013

Study shows that 23% of North Sea workers suffer from shift work disorder

Some workers in Norway's North Sea Oil industry alternate between night and day shifts, the so-called swing shift. A recent study conducted by Postdoctoral fellow Siri Waage and colleagues at the University of Bergen's Department of Global Public Health and Primary Care, shows that sleep quality and complaints of insomnia became worse during the offshore work period amongst both these swing shift workers and those who only do day shifts.

1 Jun 2013

Fatigue and sleep have predictive value for sports performance

Two new studies show that fatigue may impair strike-zone judgment during the 162 game Major League Baseball season, and a MLB player's sleepiness can predict his longevity in the league.

1 Jun 2013

Three easy steps for cancer survivorship

Incorporating just three easy steps into a daily routine can increase a cancer patient's chance at survival, according to a physician who specializes in cancer survivorship.

31 May 2013

Extremely low doses of THC protect the brain from long-term cognitive damage

Though marijuana is a well-known recreational drug, extensive scientific research has been conducted on the therapeutic properties of marijuana in the last decade. Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms.

31 May 2013

National Sleep Awareness month: ACOEM focuses on the impact of sleep disorders in workplace

In recognition of May as National Sleep Awareness month, the American College of Occupational and Environmental Medicine's ongoing awareness campaign to address chronic disease in the workplace is focusing on the impact of sleep disorders on worker health and productivity.

27 May 2013

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Astellas Pharma Inc. and Medivation, Inc. today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Labour and Welfare in Japan for the treatment of prostate cancer.

24 May 2013

Merck releases statement on FDA's Advisory Committee meeting about suvorexant

Merck, known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration about suvorexant, Merck's investigational medicine to treat insomnia.

23 May 2013

Study: Sleep disturbance may contribute to depression risk by impairing emotion regulation

A new study provides neurobiological evidence for dysfunction in the neural circuitry underlying emotion regulation in people with insomnia, which may have implications for the risk relationship between insomnia and depression.

23 May 2013

Disturbed sleep in adolescents associated with depressed mood, uncertainty about future success

A new study suggests that disturbed sleep in adolescents is associated with more symptoms of depression and greater uncertainly about future success. However, perceived support and acceptance from parents and teachers appears to have a protective effect.

23 May 2013

Studies show that LipiGesic M provides highly effective OTC solution to migraine pain

PuraMed BioScience, Inc., a researcher, developer, and marketer of over-the-counter medicinal and healthcare products, announced the results of clinical trials that found its over-the-counter migraine medication product, LipiGesic M, has "robust efficacy".

22 May 2013

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of major depressive disorder.

20 May 2013

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire plc, the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association 166th Annual Meeting in San Francisco, May 18-22.

20 May 2013

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

UCB today announced data from a double-blind, placebo-controlled study that found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure elevations associated with periodic limb movements during sleep and total PLMS in patients with idiopathic moderate-to-severe Restless Legs Syndrome/Willis-Ekbom disease.

18 May 2013

Insomnia News and Research

Latest Insomnia News and Research

Common medications reduce brain plaques in mice

Binge drinking more than 2 days per week is associated with insomnia symptoms

Review on new, hazardous drugs of abuse presented in Journal of Addiction Medicine

People with narcolepsy have increased number of neurons that produce histamine

Study demonstrates link between workplace daylight exposure to sleep, quality of life

Sleep deprivation increases men's perceptions of women's interest in sex

Study suggests bright light therapy may improve sleep and brain function post mild TBI

Study shows that 23% of North Sea workers suffer from shift work disorder

Fatigue and sleep have predictive value for sports performance

Three easy steps for cancer survivorship

Extremely low doses of THC protect the brain from long-term cognitive damage

National Sleep Awareness month: ACOEM focuses on the impact of sleep disorders in workplace

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Merck releases statement on FDA's Advisory Committee meeting about suvorexant

Study: Sleep disturbance may contribute to depression risk by impairing emotion regulation

Disturbed sleep in adolescents associated with depressed mood, uncertainty about future success

Studies show that LipiGesic M provides highly effective OTC solution to migraine pain

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Insomnia News and Research

Latest Insomnia News and Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in